𝔖 Bobbio Scriptorium

✦ LIBER ✦

Efficacy and tolerance of intermittent versus daily cotrimoxazole for PCP prophylaxis in HIV-positive patients

✍ Scribed by Rob Roy MacGregor; Amy S. Morgan; Amy L. Graziani; Nancy A. Pietroski; Ian Frank; Michael N. Braffman; John J. Stern; R.Michael Buckley

Book ID: 115684014
Publisher: Elsevier Science
Year: 1992
Tongue: English
Weight: 363 KB
Volume: 92
Category: Article
ISSN: 1555-7162
DOI: 10.1016/0002-9343(92)90122-r

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Once-daily atazanavir/ritonavir versus t

Once-daily atazanavir/ritonavir versus twice-daily lopinavir/ritonavir, each in combination with tenofovir and emtricitabine, for management of antiretroviral-naive HIV-1-infected patients: 48 week efficacy and safety results of the CASTLE study

✍ Jean-Michel Molina; Jaime Andrade-Villanueva; Juan Echevarria; Ploenchan Chetcho 📂 Article 📅 2008 🏛 The Lancet 🌐 English ⚖ 246 KB

Efficacy and tolerability of interferon

Efficacy and tolerability of interferon (Intron a) plus ribavirin (Rebetron) administered daily for two months, then thrice weekly interferon (Intron a) plus ribavirin (Rebetron), versus standard thrice weekly administration of Rebetron for the treatment of chronic hepatitis C in patients naive to interferon therapy

✍ Michael S. Epstein; Teresa DeHaemer; Patricia M. Praschak; Robert G. Finkel; Nat 📂 Article 📅 2001 🏛 Nature Publishing Group 🌐 English ⚖ 22 KB